Dr. Sean Sheridan is a principal in the Intellectual Property Practice at CRA. He has over a decade of experience working with various aspects of the intellectual property (IP) value chain including the development, valuation, commercialization, and strategic management of IP. He has provided financial consulting services for a variety of purposes including intellectual property‐related litigation, transaction due diligence, license negotiations, and strategic decision‐making. Dr. Sheridan’s project experience spans a wide range of industries, including oil and gas, biotechnology, diagnostics, pharmaceuticals, and telecommunications. He also has direct transaction experience having negotiated numerous licenses and other agreements with companies ranging from Fortune 500 firms to small start-ups.
Prior to joining CRA, Dr. Sheridan worked as a Director at Ocean Tomo. Previously, he was an Associate Director at UChicagoTech, the Center for Technology Development and Ventures at the University of Chicago.
Dr. Sheridan’s research has been published in Genes & Development, the Proceedings of the National Academy of Sciences, and Nucleic Acids Research.
PhD, Genetics, The University of Chicago
MBA, Finance, The University of Chicago Booth School of Business
BS, Biology, Appalachian State University